Neutrophil adherence and/or aggregation has been implicated in ischemia reperfusion injuries. We examined the role of P-selectin in PMN-mediated injury after reperfusion of the rabbit ear. The ear was partially amputated, and then reattached leaving the central artery and vein intact. To induce ischemia the central artery was then occluded. Treatment was at reperfusion with either saline or one of two murine P-selectin mAbs, designated PB1.3 and PNB1.6. mAb PB1.3 cross-reacts with rabbit P-selectin and prevents histamine-induced leukocyte rolling, whereas PNB1.6 does not. Using a peroxidase-antiperoxidase system P-selectin was detected in the ischemic ear, but not in the nonischemic ear. Ear volume increased to 5.3 times baseline in the saline-treated animals (n = 8), 6.6 times baseline in the nonblocking mAb PNB1.6-treated animals (n = 2), and 3.7 times baseline in the blocking mAb PB1.3-treated animals (n = 8). Estimated tissue necrosis of the combined saline-and PNB1.6-treated animals was 46 vs. 2.7% for the mAb PB1.3-treated animals. We conclude that: (a) P-selectin is expressed in ischemia reperfusion; (b) P-selectin participates in PMNendothelial cell interactions in ischemia reperfusion; and (c) inhibiting P-selectin adhesion significantly reduces reperfusion injury. (J.
Introduction
Neutrophil (PMN) migration into tissue is essential for host defense against microorganisms and for tissue repair. A critical step in their emigration and accumulation at sites ofinflammation is adherence to endothelial cells. Adherence occurs after activation of PMNs and/or endothelial cells in response to a variety of signals that cause them to become proadhesive (1) . Leukocyte adherence is followed by migration along the endothelial surface, diapedesis between endothelial cells, and migration through the interstitial space to the extravascular site (2) .
Neutrophils are potent effector cells in host defense generating many products with microbicidal activity. However, release of products such as oxidants and proteases into extracellular environment can cause blood vessel and tissue injury (3, 4) .
Ischemia followed by reperfusion can result in significant cellular injury to tissues and is important in a variety ofclinical disorders, including stroke, myocardial infarction, organ transplantation, and organ hypoperfusion. Clearly, if an organ is ischemic for a sufficient time cellular necrosis will occur and the only protection from this type of injury is prompt restoration of blood flow. However, significant injury can occur as a result of reperfusion of previously ischemic tissue (5-7). Reperfusion injury frequently is associated with activation of the inflammatory system and enhanced leukocyte-endothelial adhesiveness. We and others have shown that blocking neutrophil adherence and/or aggregation with mAbs to CDl 1 /CD1 8 glycoprotein complex can ameliorate the reperfusion injury (8) (9) (10) (11) (12) (13) .
Several adhesion molecules involved in PMN adherence to endothelium have been defined. The leukocyte #2 integrin receptor complex (CD 1 /CD 18) interacts with the endothelial ligand intercellular adhesion molecule-1 (ICAM-l ). The selectin receptors, E-, P-, and L-selectin, recognize carbohydrate counter-structures, including sialyl Lewis x (SLeX)' (reviewed in references 14 and 15) . The current model of the contribution of integrins and selectins to PMN-endothelial cell interaction is based on studies in vivo and in vitro. Observations by intravital microscopy have defined the sequence leading to leukocyte emigration at inflammatory sites. There is an initial slowing and rolling ofleukocytes followed by firm sticking and diapedesis ( 16) . Selectins appear to mediate the initial transient adhesion, which is manifested by rolling under conditions ofshear forces (17) (18) (19) . The CDl 1 /CD1 8 complex is responsible for sticking and transendothelial migration ( 16) . Consequently, defects in either integrin or selectin function will impair PMN emigration as evidenced by leukocyte adherence deficiency type I (LAD I), the congenital absence of functional CD 11/CD 18, and leukocyte adherence deficiency type II (LAD II), the congenital absence ofSLex (20) . The model also proposes that inhibition of selectin as well as integrin function should attenuate PMN-mediated vascular and tissue injury. In this regard, mAbs to E-selectin have been shown to reduce lung injury associated with the deposition of IgG immune complexes (21 ) . Also, antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys were reduced by mAbs to E-selectin (22) . In addition, mAbs to P-selectin have been shown to attenuate complement-induced lung injury (23) and ischemia reperfusion injury to the heart (24) . The experiments described herein tested the hypothesis that P-selectin is expressed on the surface of endothelial cells after ischemia and reperfusion, and this expression promotes neutrophil adherence to endothelial cells leading to a neutrophil-mediated injury. This hypothesis was formed from the synthesis ofdata in separate reports. Granger et al. (6) have shown that oxidants are produced in ischemia reperfusion injuries and scavengers of these oxidants ameliorate the injury. Patel et al. (25) reported that oxidants caused luminal expression of P-selectin, thus, P-selectin expression is predicted in ischemia reperfusion injury. This leads to the hypothesis that the initial leukocyte rolling results from their interaction with P-selectin. This hypothesis was tested using mAbs directed to a functional epitope of P-selectin to block the interaction of neutrophils with endothelial P-selectin.
Methods
New Zealand White rabbits were prepared as previously described ( 11) . Briefly, they were anesthetized with intravenous ketamine plus xylazine and nerve block at the base ofthe left ear with local lidocaine. Using sterile procedures, the left ear was partially amputated, leaving the central artery, central vein, and a narrow bridge of cartilage intact. Care was taken to insure that all blood vessels in the cartilage bridge were cut. All nerves were carefully divided to render the ear completely anesthetic. The ear was then reattached and a microvascular clip was placed across the artery to produce total ischemia. Rabbits were kept at an ambient temperature of 23.50C for 6 h, then the microvascular clamp was removed and the ear allowed to reperfuse. Treatment was given immediately before reperfusion with either saline, or an adherence-blocking P-selectin mAb (mAb PB 1.3) or a nonblocking P-selectin mAb (mAb PNB 1.6). mAbs were given by intravenous injection of 2 mg/kg, and the saline treatment group was given an equal volume of saline.
Immunocytochemistry. Punch biopsies were taken from the anesthetic ear for evaluation of P-selectin expression. Samples were taken, embedded in OTC compound (Miles, Inc.), and rapidly frozen in ethanol cooled with dry ice. P-Selectin is normally found in the WeibelPalade bodies ofthe endothelial cells and is expressed on plasma membrane after endothelial cell activation (26) . Thus, routine staining with mAbs on cut tissue might stain positive. Therefore, samples for immunohistochemistry were taken only after the animal was given P-selectin mAbs intravenously. The circulating murine mAb could attach only to luminal P-selectin and was subsequently detected with antimurine antibodies.
Cryosections were cut at 6 gm, collected onto sialinized slides, and allowed to air dry before fixation in ice-cold 4% paraformaldehyde for 10 min. Slides were washed in PBS after fixation, then incubated for 30 min with 20% normal rabbit serum in PBS to block nonspecific staining. Detection ofbound mAb was performed using reagents provide in a peroxidase-antiperoxidase immunostaining kit (Zymed Labs., Inc., S. San Francisco, CA). Briefly, this involved removal of the blocking solution, its replacement by rabbit anti-mouse Ig (bridging antibody) for 1 h, washing in PBS, then treatment with peroxidase-antiperoxidase-soluble complex for 1 h. Sections were then washed in PBS and developed with 0.03% diaminobenzidine that was sometimes followed by faint staining with hematoxylin. Ear volume and necrosis were measured as previously described ( 11) . Briefly, the ear was submerged in a beaker of water up to the suture line and its volume determined by the amount of water displaced. Necrosis was estimated from gross observation of the ear surface and expressed as a percentage of total area. Ear volume was measured daily for 7 d by water displacement to quantify tissue edema. On day 7, necrosis was estimated as a percentage oftotal surface area. The protocol ofthese experiments was approved by the University ofWashington Animal Care Committee and complies with the National Institutes of Health guidelines for care and uses of laboratory animals.
Myeloperoxidase (MPO) assay. The enzyme MPO is found in the granules of neutrophils and has been used as an indicator of PMN emigration into tissue (21, (27) (28) (29) . We used the previously described technique to determine MPO concentration (30) . Both ears of rabbits were used to measure MPO activity. The skin from 18 rabbit ears (9 saline treated and 9 mAb PB1.3 treated) was dissected offthe cartilage at 24 h after the start of ischemia, weighed, and homogenized in PBS containing 0.5% hexadecyltrimethylammonium bromide (HTAB). 1 ml ofthe PBS solution was added to 500 mg oftissue before homogenization. The homogenized solutions were freeze thawed three times and sonicated twice to disrupt the cells, then the mixture was centrifuged at 10,000 g for 10 min. The supernatant was decanted and heated at 60'C for 120 min to inactivate inhibitors of MPO activity (31 ) . The optical density has been shown to be proportional to MPO concentration (30) .
PMN infiltration. A measure of total PMN infiltration was determined from multiplying the MPO activity ofthe sample by the 24-h ear volume and dividing by the initial ear volume. Multiplication by total ear volume results in total MPO activity in the ear and correction for different initial size was made by normalization to initial ear volume. MPO content of normal ears (never ischemic) was determined in a separate set ofmeasurements and was subtracted from the values determined in ischemic ears. The resulting MPO content represents the increased MPO activity resulting from ischemia and reperfusion of the ear.
Statistics. Data were expressed as mean±SEM. Statistical significance ofthe differences between ear volume was determined by analysis of variance for repeated measures. Differences in the percent necrosis between the combined control groups (mAb PNBI.6 treated and saline treated) and the mAb PBl .3-treated animals were examined by Mann-Whitney U test Differences of P < 0.05 were considered to be statistically significant. mAb. The mAb PB 1.3 is a murine-derived IgG I directed to human P-selectin and cross-reacts with rabbit P-selectin. Also, it blocks rolling in the cat mesentery after preparation for viewing through intravital microscopy (32) . mAb PNB 1.6 is a nonblocking murine-derived IgG I also directed to human P-selectin, but does not block rolling in vivo. The intravenous injection of mAbs did not have any acute effects on circulating white blood cell counts when given to normal rabbits.
Results
Ear Volume. 6 h ofischemia at 23.5°C resulted in considerable edema in the saline-treated and mAb PNB1.6-treated rabbits with the average ear volume exceeding five and six times baseline in the two groups, respectively. There were only two animals in the PNB1 .6-treated rabbits, too few for statistical analysis, and thus, the saline-and PNB 1.6-treated rabbits were com-bined in Fig. 1 . The blocking mAb PB1.3 prevented some of the edema formation but the ear volume reached a peak of -3.7 times baseline. The combined control animals were statistically different from the mAb PBl.3-treated animals by analysis of variance for repeated measures. Necrosis. Tissue necrosis was estimated for seven of the combined control animals and for six of the mAb PB1.3-treated animals (Fig. 2) . There was considerable variability in both groups with four ofthe six mAb PB 1.3-treated and one of the control group having no necrosis. Maximum necrosis in the control group and the mAb PBl .3-treated group was '-85 and 15%, respectively. Differences among groups were significant by Mann-Whitney U test.
Myeloperoxidase. MPO content ofears from saline-treated rabbits averaged more than five times that of the mAb PB1.3-treated group. These differences were statistically significant when compared by t test (P < 0.01). These results are consistent with the hypothesis that protection afforded by the administration ofP-selectin mAbs resulted from a reduced PMN-mediated injury after ischemia and reperfusion.
Immunocytochemistry. Tissues stained for detection of Pselectin from animals given mAb PB 1.3 at the time of reperfusion are shown in Fig. 3 . A nonischemic control ear is shown in Fig. 3 A. Very faintly staining vessels were occasionally seen in control ears. An ear made ischemic and allowed to reperfuse for 4 h before tissue sampling is shown in Fig. 3 , B and C. P-Selectin staining is clearly observed as the brown oval and linear outlines in Fig. 3 B. Fig. 3 Values are mean±SEM.
Discussion
The P-selectin molecules are normally found in the a granules of platelets and in Weibel-Palade bodies of endothelial cells. Upon stimulation, these structures fuse with the cell membrane releasing their contents and exposing P-selectin to the luminal surface (33) . Endothelial cell surface expression of P-selectin after stimulation with histamine or thrombin is rapid but short lived in vitro, lasting from 30 to 60 min (26, 34) . Deposition ofthe complement proteins C5b-C9 cause surface expression, however, the time course ofexpression was not determined (35) . Continuous in vitro stimulation of endothelial cells with oxygen radicals results in P-selectin expression lasting at least 4 h (25). This expression also corresponded to adherence of PMNs to the stimulated endothelial cells and was blocked by mAbs to P-selectin (25) . More recently, P-selectin was shown to be induced by TNF in murine endothelial cells (36) . The selectin molecules (L-, P-, and E-selectin) all have similar molecular structures. These consist of a cytoplasmic domain, a transmembrane domain, a variable number of regulatory protein repeats, an EGF domain, and a lectin domain (reviewed in reference 33). The counter-structure for P-selectin on leukocytes has not been completely defined, but it recognizes the oligosaccharide SLex (37, 38 ) and a recently described glycoprotein on myeloid cells (39) . Earlier reports showed that binding of neutrophils to P-selectin was sensitive to sialidase treatment of neutrophils, suggesting that sialic acid is necessary for adherence (38, 40, 41) . Neutrophils lacking SLeX as well as other fucose-containing carbohydrate moieties from a patient with LAD II syndrome failed to bind to histamine-treated endothelial cells or purified P-selectin in vitro (Phillips, L., B. Schwartz, A. Etzioni, R. Bayer, H. Ochs, J. Paulson, and J. Harlan, manuscript in preparation), indicating that a fucose-containing carbohydrate structure is essential for binding.
PMN adherence or aggregation was shown in previous studies to Thus, the effectiveness of anti-P-selectin mAbs in ischemia reperfusion injury suggests that this molecule is responsible for the initial leukocyte-endothelial interaction.
The mediator of P-selectin expression was not examined in this study; however, it is possible that expression was due to generation of oxygen radicals beginning at the time of reperfusion. During ischemia, xanthine dehydrogenase is converted to xanthine oxidase, and upon reperfusion molecular oxygen is used as an electron donor, resulting in the production ofsuperoxide anion radical and subsequent generation of hydrogen peroxide (5) . Activation and adherence could lead to further generation of oxygen radicals by the granulocytes and additional expression of P-selectin as described by Patel et al. (25) . TNF is another potential mediator of P-selectin expression in this setting (36) .
Ischemia reperfusion injury is known to be temperature dependent. A lowering of temperature by 1 or 20C during the ischemic period allows longer ischemic times for the same degree of injury (42) . The experiments described in this paper show that the rabbit ear is no exception. Vedder et al. ( 11 ) showed an average maximum increase in ear volume equal to 4.3 times baseline in saline-treated rabbits. Ambient temperature in those experiments was -220C and the ischemia time was 10 h. By comparison, the ambient temperature was 1.5°C warmer in experiments described in this study, and ear volume increased to an average maximum 5.3 times baseline in salinetreated rabbits. Clearly, the increased temperature resulted in a more severe injury even with an ischemic time that was 4 h less than that of Vedder et al. ( 11 ) . The percentage increase in the P-selectin mAb-treated group was 3.7 times baseline compared with 3.0 times baseline for the CD18 mAb-treated rabbits. Difference in these two groups is probably due to differences in temperature.
We conclude that in rabbit ear: (a) ischemia reperfusion causes endothelial surface expression of P-selectin during reperfusion; (b) P-selectin is involved in the initial leukocytesendothelial cell interaction after reperfusion; and (c) blockade of P-selectin provides protection equivalent to CD18 blockade after ischemia and reperfusion.
